ZYXI
Zynex Inc

2,282
Mkt Cap
$42.42M
Volume
48,262.00
52W High
$9.33
52W Low
$1.23
PE Ratio
-1.50
ZYXI Fundamentals
Price
$1.36
Prev Close
$1.40
Open
$1.39
50D MA
$1.49
Beta
1.49
Avg. Volume
96,591.43
EPS (Annual)
$0.0927
P/B
33.63
Rev/Employee
$192,354.00
Loading...
Loading...
News
all
press releases
Zynex Announces Appointment of Bret Wise to Board of Directors as Audit Committee Chair
Zynex Announces Appointment of Bret Wise to Board of Directors as Audit Committee Chair Zynex Announces Appointment of Bret Wise to Board of Directors as Audit Committee Chair PR Newswire ENGLEWOOD...
PR Newswire·13d ago
News Placeholder
More News
News Placeholder
Zynex Inc. (ZYXI) Reports Q2 Loss, Misses Revenue Estimates
Zynex (ZYXI) delivered earnings and revenue surprises of -60.00% and -17.44%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Zynex Announces Partnership To Conduct Business with Veterans Affairs (VA) Medical Centers, the Largest Healthcare Network in the United States
Zynex Announces Partnership To Conduct Business with Veterans Affairs (VA) Medical Centers, the Largest Healthcare Network in the United States Zynex Announces Partnership To Conduct Business with...
PR Newswire·10mo ago
News Placeholder
Zynex UCSF Study Results Demonstrate Laser Technology Benefits in Resolving Racial Bias of Current LED Pulse Oximeters
Zynex UCSF Study Results Demonstrate Laser Technology Benefits in Resolving Racial Bias of Current LED Pulse Oximeters Zynex UCSF Study Results Demonstrate Laser Technology Benefits in Resolving...
PR Newswire·11mo ago
News Placeholder
Zynex Announces Completion of Its Laser Pulse Oximetry Trial
Zynex Announces Completion of Its Laser Pulse Oximetry Trial Zynex Announces Completion of Its Laser Pulse Oximetry Trial PR Newswire ENGLEWOOD, Colo., Dec. 5, 2024 ENGLEWOOD, Colo., Dec. 5, 2024...
PR Newswire·11mo ago
News Placeholder
Zynex Reports Third Quarter 2024 Financial Results
Zynex Reports Third Quarter 2024 Financial Results Zynex Reports Third Quarter 2024 Financial Results PR Newswire ENGLEWOOD, Colo., Oct. 24, 2024 ENGLEWOOD, Colo., Oct. 24, 2024 /PRNewswire...
PR Newswire·1y ago
News Placeholder
Zynex Sets Third Quarter 2024 Earnings Call
Zynex Sets Third Quarter 2024 Earnings Call Zynex Sets Third Quarter 2024 Earnings Call PR Newswire ENGLEWOOD, Colo., Oct. 16, 2024 ENGLEWOOD, Colo., Oct. 16, 2024 /PRNewswire/ -- Zynex, Inc...
PR Newswire·1y ago
News Placeholder
Zynex to Present at the HC Wainwright Global Investment Conference
Zynex to Present at the HC Wainwright Global Investment Conference Zynex to Present at the HC Wainwright Global Investment Conference PR Newswire ENGLEWOOD, Colo., Sept. 4, 2024 ENGLEWOOD, Colo...
PR Newswire·1y ago
News Placeholder
Zynex Obtains FDA clearance for new Pain Management Device
Zynex Obtains FDA clearance for new Pain Management Device Zynex Obtains FDA clearance for new Pain Management Device PR Newswire ENGLEWOOD, Colo., Sept. 3, 2024 ENGLEWOOD, Colo., Sept. 3, 2024...
PR Newswire·1y ago
News Placeholder
DexCom, Zynex, Olin And Other Big Stocks Moving Lower In Friday's Pre-Market Session
read more...
Benzinga·1y ago

Latest ZYXI News

View

Advertisement|Remove ads.

Advertisement|Remove ads.